lncRNA TUG1 Promotes Cisplatin Resistance by Regulating CCND2 via Epigenetically Silencing miR-194-5p in Bladder Cancer - Yu, Gan; Zhou, Hui; Yao, Weimin; Meng, Lirong; Lang, Bin (Molecular therapy. Nucleic acids, 2019)
Keywords: Apoptosis; Azacytidine; Biomarkers; Bladder cancer; Cancer; Cancer therapies; CCND2; Cell growth; Cell proliferation; Chemoresistance; Chemotherapy; Cisplatin; cisplatin resistance; Deoxyribonucleic acid; DNA; DNA methylation; Experiments; EZH2; Gene expression; Lung cancer; Lymphatic system; Medical prognosis; Metastases; methylation; miR-194-5p; Survival analysis; Taurine; Therapeutic applications; TUG1; Tumorigenesis; China; chemoresistance; CCND2; bladder cancer; cisplatin resistance; methylation; miR-194-5p; TUG1; EZH2